UTHR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - United Therapeutics Corp

Watchlist Manager

Watchlist

Price: 556.82 USD -0.94% Market Closed

Market Cap: $24.4B

	United Therapeutics Corp NASDAQ:UTHR	US
	Lineage Cell Therapeutics Inc F:BT3	US
	Nexpoint Real Estate Finance Inc NYSE:NREF	US
I	International Container Terminal Services Inc XPHS:ICT	PH
	National Beverage Corp NASDAQ:FIZZ	US
	Krafton Inc KRX:259960	KR

Profitability Summary

United Therapeutics Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

89%

Declining Gross Margin

91% > 87%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

49%

Declining Operating Margin

50% > 45%

Exceptional Net Margin

41%

Strong 3Y Average Net Margin

41%

Net Margin is Increasing

37% > 41%

Exceptional Free Cash Flow Margin

32%

Strong 3Y Average Free Cash Flow Margin

34%

Declining Free Cash Flow Margin

36% > 32%

Positive ROE

20%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

28%

ROIC is Increasing

25% > 28%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.